|Videos|May 22, 2021
Neoadjuvant Therapy for HR+ Breast Cancer
Author(s)Kevin Kalinsky, MD, MS
Dr Kevin Kalinsky describes when and for whom neoadjuvant therapy may be appropriate for the management of HR-positive breast cancer.
Advertisement
Episodes in this series
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Related Content
Advertisement
Advertisement
Trending on CancerNetwork
1
Spotlighting the Top 10 FDA Oncology Approvals in 2025
2
A Look Back on the Top 10 Oncology Interviews in 2025
3
Zovegalisib Combo Confers Efficacy Benefit in PIK3CA-Mutated Breast Cancer
4
What’s New in Hematology/Oncology? Discussing the 2025 ASH Annual Meeting
5